Clinical Trials Logo

Liver Biopsy clinical trials

View clinical trials related to Liver Biopsy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04003766 Completed - Liver Biopsy Clinical Trials

Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy

Start date: July 25, 2019
Phase: N/A
Study type: Interventional

This study is to evaluate and directly compare the technical success, tissue quality, diagnostic efficacy and safety profile of Percutaneous and Endoscopic Ultrasound-guided Liver Biopsy.

NCT ID: NCT02620228 Completed - Liver Biopsy Clinical Trials

Identification of Liver Tumours Using BIP - Biopsy System

Start date: June 9, 2016
Phase: N/A
Study type: Interventional

This clinical device investigation is conducted by performing liver biopsies using the BIP - Biopsy Tool. The aim is to assess the feasibility of bioimpedance spectroscopy based biopsy tool guidance method and test how well BIP biopsy system is able to distinguish liver tumours from surrounding tissue. In addition, user feedback is obtained to improve the usability of the investigational device. The study does not affect the traditional treatment procedure and only the patients in clinical need for diagnosis by liver biopsy are included on voluntary basis. The invasive products used in actual biopsy operation are designed so that their performance is essentially equal to the currently used biopsy devices, the only difference is the measurement capability of biopsy needle and connection to measurement device.

NCT ID: NCT00643656 Completed - Liver Biopsy Clinical Trials

Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion

Start date: October 2007
Phase: Phase 4
Study type: Interventional

A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.